Yes, my mistake. As you say, it's closer to 300 million Aussie and that makes ACADIA likely an enthusiastic bidder for ROW. Why would ACADIA want some other pharma to get ROW rights, they have spent so much money to this point, giving away all their hard work to a rival makes no sense. Of course Jon and Gerry will work for the best deal possible but it's a no brainer for me.
Share Price, page-3666
-
- There are more pages in this discussion • 7,109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |